Global Antipsychotic Drugs Market 2021-2027

February 2022 | 76 pages | ID: G5C3456BDD09EN
Gen Consulting Company

Abstracts

Antipsychotic drugs, also known as neuroleptics, are a class of psychotropic medication primarily used to manage psychosis, principally in schizophrenia but also in a range of other psychotic disorders. They are also the mainstay together with mood stabilizers in the treatment of bipolar disorder. Gen Consulting Company predicts that the global antipsychotic drugs market is estimated to touch a valuation of USD 15,763 million, registering a CAGR of 2.3% during the forecast period (2021-2027).

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global antipsychotic drugs market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the antipsychotic drugs industry.

The antipsychotic drugs market is segmented on the basis of mechanism of action, indication, and region. The antipsychotic drugs market is segmented as below:

By mechanism of action:

• D2/5HT2A antagonist
• D2 partial agonist
• others

By indication:

• schizophrenia
• bipolar disorder
• major depressive disorder
• others

By region:

• Asia Pacific
• Europe
• North America
• Rest of the World (RoW)

The report explores the recent developments and profiles of key vendors in the Global Antipsychotic Drugs Market, including Allergan plc, AstraZeneca plc, Dr. Reddy's Laboratories Ltd., Eli Lilly and Company, H. Lundbeck A/S, Janssen Pharmaceuticals, Inc. (Johnson & Johnson), Mylan N.V., Otsuka Holdings Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global antipsychotic drugs market.
• To classify and forecast the global antipsychotic drugs market based on mechanism of action, indication, and region.
• To identify drivers and challenges for the global antipsychotic drugs market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global antipsychotic drugs market.
• To identify and analyze the profile of leading players operating in the global antipsychotic drugs market.

Why Choose This Report

• Gain a reliable outlook of the global antipsychotic drugs market forecasts from 2021 to 2027 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

1.1 Market definition
1.2 Key benefits
1.3 Market segment

PART 2. METHODOLOGY

2.1 Primary
2.2 Secondary

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

4.1 Introduction
4.2 Market dynamics
  4.2.1 Drivers
  4.2.2 Restraints

PART 5. GLOBAL MARKET FOR ANTIPSYCHOTIC DRUGS BY MECHANISM OF ACTION

5.1 D2/5HT2A antagonist
  5.1.1 Market size and forecast
5.2 D2 partial agonist
  5.2.1 Market size and forecast
5.3 Others
  5.3.1 Market size and forecast

PART 6. GLOBAL MARKET FOR ANTIPSYCHOTIC DRUGS BY INDICATION

6.1 Schizophrenia
  6.1.1 Market size and forecast
6.2 Bipolar disorder
  6.2.1 Market size and forecast
6.3 Major depressive disorder
  6.3.1 Market size and forecast
6.4 Others
  6.4.1 Market size and forecast

PART 7. GLOBAL MARKET FOR ANTIPSYCHOTIC DRUGS BY REGION

7.1 Asia Pacific
  7.1.1 Market size and forecast
7.2 Europe
  7.2.1 Market size and forecast
7.3 North America
  7.3.1 Market size and forecast
7.4 Rest of the World (RoW)
  7.4.1 Market size and forecast

PART 8. KEY COMPETITOR PROFILES

8.1 Allergan plc
8.2 AstraZeneca plc
8.3 Dr. Reddy's Laboratories Ltd.
8.4 Eli Lilly and Company
8.5 H. Lundbeck A/S
8.6 Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
8.7 Mylan N.V.
8.8 Otsuka Holdings Co., Ltd.
8.9 Sumitomo Dainippon Pharma Co., Ltd.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
ABOUT GEN CONSULTING COMPANY